CN Patent

CN117769545A — 含三并环类衍生物调节剂、其制备方法和应用

Assigned to Shanghai Shujing Biotechnology Co ltd · Expires 2024-03-26 · 2y expired

What this patent protects

涉及含三并环类衍生物调节剂、其制备方法和应用。特别地，涉及通式(Ia)所示的化合物、其制备方法及含有该化合物的药物组合物，及其在制备预防和/或治疗与哺乳动物5‑羟色胺和/或多巴胺和/或去甲肾上腺素神经递质传递相关的中枢神经系统疾病和/或外周疾病药物中的应用。

USPTO Abstract

涉及含三并环类衍生物调节剂、其制备方法和应用。特别地，涉及通式(Ia)所示的化合物、其制备方法及含有该化合物的药物组合物，及其在制备预防和/或治疗与哺乳动物5‑羟色胺和/或多巴胺和/或去甲肾上腺素神经递质传递相关的中枢神经系统疾病和/或外周疾病药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN117769545A
Jurisdiction
CN
Classification
—
Expires
2024-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Shujing Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.